Response assessment in metronomic chemotherapy: RECIST or PERCIST?

INTRODUCTION: Metronomic chemotherapy (MC) is a novel therapeutic variation for resistant cancers, wherein chemotherapeutic drugs are administrated in low doses with no prolonged drug-free break. It lessens the level of toxicity, is better tolerated and enhances the quality of life. This retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Archi, Purandare, Nilendu, Shah, Sneha, Puranik, Ameya, Banavali, Shripad, Rangarajan, Venkatesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996775/
https://www.ncbi.nlm.nih.gov/pubmed/24761057
http://dx.doi.org/10.4103/0972-3919.130285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996775/
https://www.ncbi.nlm.nih.gov/pubmed/24761057
http://dx.doi.org/10.4103/0972-3919.130285

Ejemplares similares